Angina pectoris in women: focus on microvascular disease

Cinzia Zuchi1, Isabella Tritto, Giuseppe Ambrosio

  • 1Department of Cardiology, University of Perugia School of Medicine, Perugia, Italy.

Insights

Ischemic heart disease (IHD) in women is underdiagnosed and undertreated, often due to microvascular angina. New treatments show promise for improving outcomes in these patients.

Area of Science:

  • Cardiology
  • Women's Health
  • Internal Medicine

Background:

  • Ischemic heart disease (IHD) is the primary cause of death for women in Western nations, presenting with higher morbidity and mortality than in men.
  • A common misconception of female protection against cardiovascular disease leads to underdiagnosis and undertreatment of IHD in women, despite their high risk for cardiovascular events.
  • Women with angina pectoris often exhibit distinct characteristics, including a high prevalence of non-significant coronary artery disease and a greater likelihood of microvascular angina compared to men.

Purpose of the Study:

  • To highlight the unique challenges in diagnosing and managing ischemic heart disease (IHD) in women.
  • To address the suboptimal diagnostic algorithms and clinical management strategies for IHD in women, particularly those with microvascular angina.
  • To underscore the need for further research and development of effective therapies for IHD in women, given their underrepresentation in clinical trials.

Main Methods:

  • Review of existing literature on ischemic heart disease (IHD) in women, focusing on diagnostic challenges and treatment efficacy.
  • Analysis of the pathophysiology of angina in women, emphasizing the role of microvascular dysfunction.
  • Examination of clinical trial data and therapeutic responses to antianginal drugs in female populations.

Main Results:

  • Standard diagnostic approaches for IHD may be suboptimal in women due to the higher prevalence of microvascular angina.
  • Women with microvascular angina often remain symptomatic despite maximal therapy with traditional antianginal drugs.
  • Limited representation of women in clinical trials hinders the understanding of gender-specific efficacy for antianginal medications.

Conclusions:

  • Women with angina represent a distinct patient group requiring tailored diagnostic and therapeutic strategies.
  • Further research is crucial to develop and validate effective treatments for IHD in women, especially those with microvascular origins.
  • Concentrated efforts on improving the quality of life and reducing morbidity in women with angina are warranted.

Related Concept Videos

Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...